Asset Dedication LLC’s ResMed RMD Stock Holding History

Asset Dedication LLC’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-5	Closed	-$1.29K	–	1224
2025 Q2	$1.29K	Hold	5	–	–	﹤0.01%	1064
2025 Q1	$1.12K	Buy	+5	New	+$1.17K	﹤0.01%	1011
2023 Q3	–	Sell	-2	Closed	–	–	1049
2023 Q2	$0	Hold	2	–	–	﹤0.01%	1025
2023 Q1	$0	Hold	2	–	–	﹤0.01%	1053
2022 Q4	$0	Buy	+2	New	+$439	﹤0.01%	1111
2021 Q3	–	Sell	-175	Closed	-$43K	–	1022
2021 Q2	$43K	Hold	175	–	–	0.01%	426
2021 Q1	$34K	Hold	175	–	–	0.01%	377
2020 Q4	$37K	Hold	175	–	–	0.01%	397
2020 Q3	$30K	Hold	175	–	–	0.01%	389
2020 Q2	$34K	Hold	175	–	–	0.01%	346
2020 Q1	$26K	Hold	175	–	–	0.01%	370
2019 Q4	$27K	Hold	175	–	–	0.01%	367
2019 Q3	$24K	Hold	175	–	–	0.01%	368
2019 Q2	$21K	Hold	175	–	–	0.01%	370
2019 Q1	$18K	Hold	175	–	–	0.01%	393
2018 Q4	$20K	Hold	175	–	–	0.01%	362
2018 Q3	$20K	Buy	+175	New	+$19.2K	0.01%	364

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Asset Dedication LLC's RMD Position: Q3 2025 in Review

Asset Dedication LLC sold out of ResMed (RMD) in Q3 2025, closing a stake of 5 shares — an estimated $1.29K sold.

Asset Dedication LLC first reported a position in RMD in Q3 2018 and held it in 17 quarters. The position peaked at $43K in Q2 2021. 950 funds tracked by Wall St. Rank hold RMD as of Q3 2025.

Asset Dedication LLC reported no remaining ResMed position as of Q3 2025 after selling out during the quarter.
Asset Dedication LLC sold 5 ResMed shares in Q3 2025, an estimated $1.29K.
Asset Dedication LLC first reported a position in ResMed in Q3 2018 and held it in 17 quarters.
Asset Dedication LLC's ResMed position peaked at $43K in Q2 2021.
950 funds tracked by Wall St. Rank held ResMed as of Q3 2025.

Based on Asset Dedication LLC's 13F filing for Q3 2025, filed 20 Nov 2025.